Chengsen Cui

Title: Chengsen Cui: Innovator in Diterpenoid Synthesis

Introduction

Chengsen Cui is a notable inventor based in West Lafayette, IN (US). He has made significant contributions to the field of organic chemistry, particularly in the synthesis of natural products. His work has implications for cancer treatment and drug development.

Latest Patents

Chengsen Cui holds a patent for "Curcusone diterpenoids and uses thereof." This patent presents the first asymmetric total synthesis and target identification of curcusone natural products. The innovative synthesis utilizes a cost-effective chiral pool molecule and incorporates a thermal [3,3]-sigmatropic rearrangement along with an FeCl3-promoted global hydrolysis/aldol condensation cascade. This method efficiently constructs the critical cycloheptadienone core. Notably, the compound identified as 1d inhibits the oncogenic protein BRAT1, which plays a crucial role in cancer cell behavior. This discovery positions 1d as the first known small-molecule inhibitor for BRAT1, enhancing its potential in cancer therapy.

Career Highlights

Chengsen Cui has worked with reputable organizations such as the Purdue Research Foundation and the University of Florida Research Foundation Inc. His research has focused on the intersection of chemistry and medicine, aiming to develop new therapeutic strategies.

Collaborations

Chengsen has collaborated with esteemed colleagues, including Mingji Dai and Alexander Adibekian. These partnerships have contributed to the advancement of his research and the successful development of innovative solutions in the field.

Conclusion

Chengsen Cui's work in the synthesis of curcusone diterpenoids exemplifies the impact of innovative research on cancer treatment. His contributions to organic chemistry and collaborations with other experts highlight the importance of interdisciplinary efforts in advancing medical science.